Search
Cytosorbents Corp
CTSOAdd to Watchlist
4.230USD
+0.110+2.67%
Market hours 11/03, 11:04（ET）
13.32MMarket Cap
LossP/E TTM
Cytosorbents Corp (CTSO) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to Cytosorbents Corp in the past month.
Buy
0 Strong Buy
1 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
34.833USD+564.76%
CTSO Analyst Recommendation Trends
In the current month, CTSO has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CTSO average Analyst price target in the last month is 34.833.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
1
1
0
0
0
0
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
1
1
1
1
2
2
CTSO Analyst Rating for Peer Comparison
Updated: Nov 1, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
14
8
1
0
34
Boston Scientific Corp
BSX
7
14
11
1
0
33
Edwards Lifesciences Corp
EW
10
15
6
0
0
31
Thermo Fisher Scientific Inc
TMO
10
14
6
0
0
30
Veeva Systems Inc
VEEV
8
13
7
1
0
29
Danaher Corp
DHR
11
13
3
0
0
27
Agilent Technologies Inc
A
6
11
7
0
0
24
Waters Corp
WAT
8
10
6
0
0
24
GE Healthcare Technologies Inc
GEHC
6
10
7
0
0
23
Resmed Inc
RMD
3
8
10
1
1
23
Financial Forecasting
Based on analysts' estimates, CTSO EPS is projected to reach -0.900 in FY2026Q3, following reported EPS of -1.407 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.00
-1.10
-0.90
-0.90
-0.70
Actual
-0.13
-1.64
-1.41
--
--
Surprise
+86.83%
-48.64%
-56.29%
--
--
FAQs
What is Cytosorbents Corp's expected revenue for the next quarter?
Cytosorbents Corp's expected revenue is 9.91M.
What is Cytosorbents Corp's price target?
Analysts forecast that Cytosorbents Corp's price target is USD 34.83, with the highest forecast at USD 80.00 and the lowest forecast at USD 9.50.
How have Cytosorbents CorpCTSO's recent earnings per share performed?
The market expectation was USD -1.41, while Cytosorbents CorpCTSO's earnings per share (EPS) for the previous quarter was USD -1.64. EPS for the next quarter is expected at USD -0.90.
What is the analyst rating for Cytosorbents Corp?
Based on the ratings of Cytosorbents Corp's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.